Global Lumpectomy Market Overview:
Growing incidences of breast cancer will help to boost global lumpectomy market. Lumpectomy is also called as breast-conserving surgery and wide local excision. Lumpectomy is a type of surgery to remove cancer or other abnormal tissue from the breast. In this process the only portion of the breast. It helps in confirming the diagnosis and complete absence of cancer. Additionally, it is a premier treatment option for some women with early-stage breast cancer. Some of the key players profiled in the study are Sanarus (United States), ClearCut Medical (Israel), BD (United States), Vector Surgical (United States), Dune Medical Devices (Georgia), Medtronic PLC (Ireland), ZEISS (Germany), Hologic, Inc. (United States), Novian Health, Inc. (United States) and Cianna Medical (Merit Medical Systems, Inc.) (United States).
On the basis of geography, the market of Lumpectomy has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Europe on the other hand stood as second largest market due to the presence of key companies into the region and high technological advancement. If we see Market by End User, the sub-segment i.e. Hospitals will boost the Lumpectomy market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increase in Prevalence of Breast Cancer
- Growing In Government Initiative
- Fueling Usage of Mammography for Breast Cancer Detection
- Upsurge Awareness of Breast Cancer
- Stringent Government Regulations about Testing
- High Cost of Procedure
- Technological Advancement in Lumpectomy Market
- Huge Opportunity in Emerging Economic and Highest Growth Region
- Unavailability of Government Programs for Young Women
Major Market Developments:
On 25th April 2019, Hologic, Inc. has announced global commercial availability of the Trident® HD specimen radiography system, a next-generation solution that delivers enhanced image quality, improved workflow, and instant sample verification during breast-conserving surgeries as well as stereotactic breast biopsies.
On 12th February 2019, Dune Medical Devices recently reached the halfway point in a Post-Approval Study (PAS) for MarginProbe, with over 275 patients enrolled in the third Randomized Controlled trial on MarginProbe. and On 26th September 2018, Hologic, Inc. a global leader in women’s health has acquired Focal Therapeutics, a privately-held company. In conjunction with Hologic’s recent acquisition of Faxitron Bioptics, Focal strengthens the Company’s position in the rapidly growing market for breast-conserving surgery. The deal was established for 125 million dollars.
Medical Device Manufactures, Distributors and Suppliers, Government Regulatory Bodies, Government and Private Research Organizations and Others
Major Objectives Focused through this Study
To define, describe, and forecast the Global Lumpectomy market on the basis of product [Surgical Tools and Lumpectomy Systems] , application , key regions and end user
To provide in-depth information regarding major influencing factors affecting the growth of the market (trends, drivers, restraints, opportunities, and industry-centric and regional challenges)
To strategically analyse the micro-markets and important business segments with respect to individual growth drivers , market trends and potential, and historical contributions to the total market
Identifying the opportunities in the market for key stakeholders and detailing the competitive landscape for market leaders
To provide market size for various segments of the Lumpectomy market with respect to major geographies, namely, South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico)
To strategically profile the key players and analyzing their market shares and core competencies in the Lumpectomy industry
To track key developments such as product launches, expansions, agreements, partnerships, mergers & acquisitions, and R&D activities that are key factors in shaping the market
Available Customization: Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**. Additionally, the Players which are also part of the research are Endomagnetics (United Kingdom) and Cook Medical (United States).
** Confirmation on availability of data would be informed prior purchase
While framing the research framework, major and emerging players operating in the Lumpectomy market in various regions have been profiled, and their offerings, geographic footprints, and distribution/sales channels have been analysed through in-depth discussions. Top-down and bottom-up approaches have been used to determine the overall market size. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Dow Jones (Factiva), along with primary respondents. The complete methodology includes the study of the annual and financial reports of the key market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) related to the market.